Skip to main content
July 2, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Home
Neuroendocrine Tumors
Neuroendocrine Tumors
Neuroendocrine Tumors
The CancerConnect Neuroendocrine Tumors Newsletter
By TraceyS
Feb 3, 2019
Neuroendocrine Tumors
Lutathera Pepetide Receptor Radionuclide Therapy for NETs
By CancerConnect
Aug 17, 2018
Neuroendocrine Tumors
FDA Approves Lutathera for Treatment for Certain Digestive Tract Cancers
By CancerConnect
Aug 10, 2018
Neuroendocrine Tumors
Azedra® - Frequently Asked Questions About Azedra® (iobenguane I 131)
By TraceyS
Aug 7, 2018
Neuroendocrine Tumors
FDA Designates Therapy for Azedra in Pheochromocytoma and Paraganglioma
By CancerConnect
Aug 3, 2018
Neuroendocrine Tumors
FDA Approves Iobenguane I 131 (Azedra) for Rare Neuroendocrine Tumors
By CancerConnect
Aug 2, 2018
Neuroendocrine Tumors
Xermelo-new option for controlling symptoms of Carcinoid Syndrome
By CancerConnect
Aug 1, 2018
Neuroendocrine Tumors
Afinitor Promising in Neuroendocrine Tumors Originating in GastrointestinalTract
By CancerConnect
Jul 26, 2018
Neuroendocrine Tumors
Sutent Delays Progression of Pancreatic Neuroendocrine Tumors
By CancerConnect
Jul 4, 2018
Neuroendocrine Tumors
Sutent Approved for Pancreatic Neuroendocrine Tumors (PNET)
By CancerConnect
Jul 3, 2018
Neuroendocrine Tumors
Afinitor and Temodar Active against Pancreatic Neuroendocrine Tumors
By CancerConnect
Jul 1, 2018
Neuroendocrine Tumors
Afinitor Approved for Pancreatic Neuroendocrine Tumors
By CancerConnect
Jun 29, 2018
Neuroendocrine Tumors
Afinitor Delays Progression of Advanced Pancreatic Neuroendocrine Tumors
By CancerConnect
Jun 14, 2018
Neuroendocrine Tumors
CancerConnect Launches On line Community for Patients with Neuroendocrine Tumors
By CancerConnect
Jun 1, 2018
Neuroendocrine Tumors
Delcath Receives Orphan Drug Designation for Treatment of Neuroendocrine Tumors
By CancerConnect
Dec 10, 2009
CLOSE
CLOSE
CLOSE
CLOSE
